Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T16:29:18.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the change.
    Difference
    1%
    Check dated 2026-10-25T17:21:24.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:38:58.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.0 to v3.7.1 on the forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T22:40:32.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the expected study content and blocking access to the NCT03318939 record. This appears to be an access/configuration issue rather than a content update.
    Difference
    19%
    Check dated 2026-09-20T19:53:33.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new site revision entry v3.6.6 was added to the change log, and the prior revision v3.6.5 was removed. This indicates a maintenance/patch update to the site, not a change to the study content or functionality.
    Difference
    0.0%
    Check dated 2026-08-30T06:49:21.000Z thumbnail image

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.